Ascentage Pharma
AAPG16.8053.56% ( -0.620 )
Ascentage Pharma (AAPG)
Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related d...
- Open
- 17.550
- High
- 17.550
- Low
- 16.750
- Prev. Close
- 17.425
- Volume
- 14.16K
- Turnover
- 240.21K
- Avg Price
- 16.969
- Bid/Ask Ratio
- --
- Amplitude
- 4.59%
- 52wk High
- 48.450
- Volume Ratio
- 1.61
- Turnover Ratio
- 0.02%
Ascentage Pharma Analyst Rating
View MoreForecast & Rating
Jul 24, 2026Price forecast
$47.56182.98%
Forecast & RatingStrong buy
9analysts
- Strong buy77.78%
- Buy22.22%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Market Beat · 3 hours ago
Ascentage Pharma Group International (NASDAQ:AAPG) Stock Price Down 4.6% - Here's Why
- StockTitan · 1 day ago, 10:30 AM
Ascentage Pharma Appoints Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer | AAPG Stock News
- StockTitan · Jul 26 at 10:30 AM
Ascentage Pharma Chairman and CEO Dr. Dajun Yang Named to The Medicine Maker Power List 2026 | AAPG Stock News
- Market Beat · Jul 25 at 08:20 AM
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG) Short Interest Down 87.2% in July
- Tip Ranks · Jul 20 at 07:48 AM
Ascentage Pharma Sets Up US$200 Million Nasdaq ATM Offering Following SEC Shelf Filing
- AASTOCKS News · Jul 19 at 08:10 PM
ASCENTAGE Plans ATM Offering of ADSs in US to Raise Up to USD200 million
